Cargando…
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans
BACKGROUND AND OBJECTIVES: Since there is no clear evidence in the literature to show how non-modified single-stranded DNA (ssDNA) drugs are metabolized in humans, we assessed the metabolism of BC 007, an ssDNA therapeutic, under development as a neutralizer of autoantibodies against G-protein-coupl...
Autores principales: | Davideit, Hanna, Becker, Susanne, Müller, Johannes, Becker, Niels-Peter, Göttel, Peter, Abay, Ayşe, Sinn, Angela, Grossmann, Matthias, Mallek, Markus, Haberland, Annekathrin, Weisshoff, Hardy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617257/ https://www.ncbi.nlm.nih.gov/pubmed/30674038 http://dx.doi.org/10.1007/s13318-019-00541-3 |
Ejemplares similares
-
Aptamer BC 007 - Efficient binder of spreading-crucial SARS-CoV-2 proteins
por: Weisshoff, Hardy, et al.
Publicado: (2020) -
Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies
por: Haberland, Annekathrin, et al.
Publicado: (2021) -
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
por: Becker, Niels-Peter, et al.
Publicado: (2020) -
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
por: Werner, Sabine, et al.
Publicado: (2020) -
Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy
por: Wenzel, Katrin, et al.
Publicado: (2017)